Intensive dose of rosuvastatin (40 mg/day), initiated early and continued for 12 weeks, in ‘very high’ risk or ‘high’ risk Indian patients

Autor:	S. Suryawanshi, J. Karankumar, Sameer Dani, B.B. Chanana, P. Moorthy, C.P. Shah, N.C. Krishnamani, S.S. Lakshmanan, B.P. Shah, G.P. Ratnaparkhi, Ashwani Mehta, K.M.K. Reddy, M.S.S. Mukharjee
Rok vydání:	2014
Předmět:	Pediatrics medicine.medical_specialty RD1-811 business.industry RC666-701 medicine Diseases of the circulatory (Cardiovascular) system Surgery Rosuvastatin Cardiology and Cardiovascular Medicine business Very high risk medicine.drug
Zdroj:	Indian Heart Journal, Vol 66, Iss S2, Pp S28-S29 (2014)
ISSN:	0019-4832
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8d73a4f1a69f1da25294cc0304fd517 https://doi.org/10.1016/j.ihj.2014.10.080 Zobrazit plný text záznamu